Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 1/2014

01-01-2014

New paradigms in thrombosis: novel mediators and biomarkers platelet RNA transfer

Authors: Lauren Clancy, Jane E. Freedman

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2014

Login to get access

Abstract

Platelets, anucleated cells with a central role in hemostasis and inflammation, contain messenger RNAs and microRNAs of unknown functionality and clinical relevance. Historically, platelet RNA was viewed as merely a remnant of platelet biogenesis; however, several studies now refute this assumption. Studies have shown that platelets can actively translate RNA to protein and that specific RNA profiles correlate with select human clinical phenotypes. These studies support a more fluid role for platelet RNA in platelet function and disease development. Our lab and others have recently studied the platelet’s unique ability to transfer RNA to recipient cells and the effect this transfer has on the recipient cells’ functions. This transfer may represent a previously unknown form of vascular cell communication and modulation. Unlike the well-characterized thrombotic properties of platelets, the nature and purpose of platelet RNA transfer has not been determined, partly due to limitations in techniques used to manipulate platelet RNA profiles. Defining the mechanism of RNA transfer and its role in the vascular system will allow for the better understanding of how platelets function in both their traditional thrombotic role and non-traditional functions, potentially having widespread implications in several fields.
Literature
3.
go back to reference Bugert P, Dugrillon A, Gunaydin A, Eichler H, Kluter H (2003) Messenger RNA profiling of human platelets by microarray hybridization. Thromb Haemost 90(4):738–748. doi:10.1267/THRO03040738 PubMed Bugert P, Dugrillon A, Gunaydin A, Eichler H, Kluter H (2003) Messenger RNA profiling of human platelets by microarray hybridization. Thromb Haemost 90(4):738–748. doi:10.​1267/​THRO03040738 PubMed
5.
6.
go back to reference Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, Yost CC, Zimmerman GA, Weyrich AS (2011) Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 118(14):e101–e111. doi:10.1182/blood-2011-03-339705 CrossRef Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, Yost CC, Zimmerman GA, Weyrich AS (2011) Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 118(14):e101–e111. doi:10.​1182/​blood-2011-03-339705 CrossRef
8.
go back to reference Gnatenko DV, Cupit LD, Huang EC, Dhundale A, Perrotta PL, Bahou WF (2005) Platelets express steroidogenic 17beta-hydroxysteroid dehydrogenases. Distinct profiles predict the essential thrombocythemic phenotype. Thromb Haemost 94(2):412–421. doi:05080412 PubMed Gnatenko DV, Cupit LD, Huang EC, Dhundale A, Perrotta PL, Bahou WF (2005) Platelets express steroidogenic 17beta-hydroxysteroid dehydrogenases. Distinct profiles predict the essential thrombocythemic phenotype. Thromb Haemost 94(2):412–421. doi:05080412 PubMed
10.
go back to reference Lood C, Amisten S, Gullstrand B, Jonsen A, Allhorn M, Truedsson L, Sturfelt G, Erlinge D, Bengtsson AA (2010) Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. Blood 116(11):1951–1957. doi:10.1182/blood-2010-03-274605 PubMedCrossRef Lood C, Amisten S, Gullstrand B, Jonsen A, Allhorn M, Truedsson L, Sturfelt G, Erlinge D, Bengtsson AA (2010) Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. Blood 116(11):1951–1957. doi:10.​1182/​blood-2010-03-274605 PubMedCrossRef
12.
go back to reference Raghavachari N, Xu X, Harris A, Villagra J, Logun C, Barb J, Solomon MA, Suffredini AF, Danner RL, Kato G, Munson PJ, Morris SM Jr, Gladwin MT (2007) Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation 115(12):1551–1562. doi:10.1161/CIRCULATIONAHA.106.658641 PubMedCentralPubMedCrossRef Raghavachari N, Xu X, Harris A, Villagra J, Logun C, Barb J, Solomon MA, Suffredini AF, Danner RL, Kato G, Munson PJ, Morris SM Jr, Gladwin MT (2007) Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation 115(12):1551–1562. doi:10.​1161/​CIRCULATIONAHA.​106.​658641 PubMedCentralPubMedCrossRef
15.
go back to reference Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94(11):3791–3799PubMed Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94(11):3791–3799PubMed
16.
go back to reference Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan ML, Karlsson JM, Baty CJ, Gibson GA, Erdos G, Wang Z, Milosevic J, Tkacheva OA, Divito SJ, Jordan R, Lyons-Weiler J, Watkins SC, Morelli AE (2012) Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119(3):756–766. doi:10.1182/blood-2011-02-338004 PubMedCrossRef Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan ML, Karlsson JM, Baty CJ, Gibson GA, Erdos G, Wang Z, Milosevic J, Tkacheva OA, Divito SJ, Jordan R, Lyons-Weiler J, Watkins SC, Morelli AE (2012) Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119(3):756–766. doi:10.​1182/​blood-2011-02-338004 PubMedCrossRef
17.
go back to reference Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659. doi:10.1038/ncb1596 PubMedCrossRef Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659. doi:10.​1038/​ncb1596 PubMedCrossRef
20.
go back to reference Takeuchi K, Satoh M, Kuno H, Yoshida T, Kondo H, Takeuchi M (1998) Platelet-like particle formation in the human megakaryoblastic leukaemia cell lines, MEG-01 and MEG-01 s. Br J Haematol 100(2):436–444PubMedCrossRef Takeuchi K, Satoh M, Kuno H, Yoshida T, Kondo H, Takeuchi M (1998) Platelet-like particle formation in the human megakaryoblastic leukaemia cell lines, MEG-01 and MEG-01 s. Br J Haematol 100(2):436–444PubMedCrossRef
21.
go back to reference Stratz C, Nuhrenberg TG, Binder H, Valina CM, Trenk D, Hochholzer W, Neumann FJ, Fiebich BL (2012) Micro-array profiling exhibits remarkable intra-individual stability of human platelet micro-RNA. Thromb Haemost 107(4):634–641. doi:10.1160/TH11-10-0742 PubMedCrossRef Stratz C, Nuhrenberg TG, Binder H, Valina CM, Trenk D, Hochholzer W, Neumann FJ, Fiebich BL (2012) Micro-array profiling exhibits remarkable intra-individual stability of human platelet micro-RNA. Thromb Haemost 107(4):634–641. doi:10.​1160/​TH11-10-0742 PubMedCrossRef
23.
go back to reference Gidlöf O, van der Brug M, Ohman J, Gilje P, Olde B, Wahlestedt C, Erlinge D (2013) Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood 121(19):3908–3917. doi:10.1182/blood-2012-10-461798 PubMedCrossRef Gidlöf O, van der Brug M, Ohman J, Gilje P, Olde B, Wahlestedt C, Erlinge D (2013) Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood 121(19):3908–3917. doi:10.​1182/​blood-2012-10-461798 PubMedCrossRef
24.
go back to reference Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Urbanowicz B, Branski P, Ratajczak MZ, Zembala M (2006) Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother 55(7):808–818. doi:10.1007/s00262-005-0075-9 PubMedCrossRef Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Urbanowicz B, Branski P, Ratajczak MZ, Zembala M (2006) Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother 55(7):808–818. doi:10.​1007/​s00262-005-0075-9 PubMedCrossRef
25.
go back to reference Laffont B, Corduan A, Ple H, Duchez AC, Cloutier N, Boilard E, Provost P (2013) Activated platelets can deliver mRNA regulatory Ago2bulletmicroRNA complexes to endothelial cells via microparticles. Blood 122(2):253–261. doi:10.1182/blood-2013-03-492801 PubMedCrossRef Laffont B, Corduan A, Ple H, Duchez AC, Cloutier N, Boilard E, Provost P (2013) Activated platelets can deliver mRNA regulatory Ago2bulletmicroRNA complexes to endothelial cells via microparticles. Blood 122(2):253–261. doi:10.​1182/​blood-2013-03-492801 PubMedCrossRef
Metadata
Title
New paradigms in thrombosis: novel mediators and biomarkers platelet RNA transfer
Authors
Lauren Clancy
Jane E. Freedman
Publication date
01-01-2014
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2014
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-013-1001-1

Other articles of this Issue 1/2014

Journal of Thrombosis and Thrombolysis 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.